Divergent synthetic nucleotide motif recognition pattern: design and development of potent immunomodulatory oligodeoxyribonucleotide agents with distinct cytokine induction profiles
Ekambar R. Kandimalla(Idera Pharmaceuticals (United States))
Cited by 65
Related Papers
Design, synthesis and biological evaluation of novel antagonist compounds of Toll-like receptors 7, 8 and 9
|Nucleic Acids Research|2013|65
Cutting Edge: The UNC93B1 Tyrosine-Based Motif Regulates Trafficking and TLR Responses via Separate Mechanisms
|The Journal of Immunology|2014|36